🇺🇸 FDA
Patent

US 9375424

Compounds that treat malaria and prevent malaria transmission

granted A61KA61K31/14A61K31/337

Quick answer

US patent 9375424 (Compounds that treat malaria and prevent malaria transmission) held by The United States of America as Represented by the Secretary, Dept. of Health and Human Services expires Mon Jun 23 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as Represented by the Secretary, Dept. of Health and Human Services
Grant date
Tue Jun 28 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 23 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
7
CPC classes
A61K, A61K31/14, A61K31/337, A61K31/366, A61K31/4535